INTRODUCTION
Drug utilization is defined as the study of usage of drugs in the community or race. The drug utilization evaluation studies (DUES) aims to analyse the rationality of drugs usage and also describes the nature and drug exposure,and may also help to identify non-adherence problems. In a developing country India, Diabetes mellitus is a clinical issue in population. The type II diabetes mellitus has more prevalence among Indian individuals.
Diabetes Mellitus complicationsare likely to reduce the quality of life of patient and owned as national public health issue 3 . Type II diabetes population have higher risk of death from CVD when compared to non-diabetes population. Type II diabetes population ofmajorityis under the general practitioners and efficiently able to control hyperglycemias. Specialists are credited for the failure of achievement of glycaemic control.Specialists like cardiologists, endocrinologists, ophthalmologists plays prominent role.In critical care both Type-I and Type-II Diabetes management is done by Insulintherapy and educating patients. Self management is known aspectin Diabetic population.Prevalence in India is increasing day by day and the awareness in the increase population is rare. These two are the main factors which are really affecting the Indian public health and quality of life. Complications that affect the quality life are diabetic nephropathy, diabetic retinopathy and diabetic neuropathy occurring due to poor glycaemic control.By creating awareness improves cost effectiveness and benefits the diabetic patient quality of life.Requirement of rationalized therapy, proper monitoring and proper patient counselling that helps patients in attaining glycaemic control. Adherence to diet, drugs, exercise, monitoring of blood glucose, care of foot are the self care activities. Proper assessment of patient clinical condition and knowledge of self management on diabetes enacts proper interventions to be effective in glycaemic control in various studies. 6 Invigorate assessment of glycaemic control in diabetics patients likely avoids different complications of eye, Heart, kidney, etc.
Factors that contributes to DM:
Highly increased glucose level (hyperglycaemia) is referred as Diabetes. Type II diabetespatients can also have hypertension, chronic high levels of insulin and hyperlipidaemia. These factors contribute to the longterm complications of diabetes includes the following: Impact on memory: Studies have shown diabetes to increased risk factor of memory loss, early Alzheimer's disease and also cognitive deficits.
Diabetic neuropathy: Peripheral neuropathy always causes pain otherwise numbness in the limbs, and autonomic neuropathy, which causesgastro-paresis and contributes to decreased sexual instinct and incontinence. 
Musculo-skeletal disorders:
Conditions from gout to osteoporosis and restless legs syndrome to myofascial pain syndrome ranges more commonly in diabetic patients 7 .
There are several guidelinesexisting for diabetes management by maintaining proper diet.The guidelines are proposed to provide evidence-based nutritional recommendations by healthcare professionals for the people who are at risk of, and those living with complications. Appropriate food choices are proven to reduce the risk of Type II diabetes and diabetesassociated tissue damage obtains optimal glycaemic control and increases the quality of life. Specified diet is an important put forth for diabetic patient in the effective management of diabetes and helps to maintain optimal glycaemic control and reduces the risk of long-term tissue damage. The Diabetes UK 2011 explores to the extent that all members of the multidisciplinary team can deliver and implement evidence-based nutritional advices. All advices should be based upon scientific evidence-based and taking an account of personal and cultural preferences, beliefs, lifestyle; and the advices should beprovided for an individual in lucid language either by orally or as a leaflet or both preferably by patient.
Notably, these guidelines are to be:  Support self-management to reduce the complications of Type II diabetes and the comorbidities associated  To improve quality of life  To meet the needs of all individuals, including those with co-morbidities; e.g. coeliac disease and cystic fibrosis 8 .
Cancer: Diabetes increases the risk of malignant tumours in thepancreas, colon, liver and several other organs.
OBJECTIVES General objective:
 To evaluate the Drug utilization in diabetic patients in a tertiary care teaching hospital.
Specific objectives:
 
Study design:
Thestudy was a prospective observational study, which assessed the drug utilization in diabetic patients.
Study duration:
The study was conducted for a period of six months from December 2012 to May 2013.
Study criteria:
 Inclusion Criteria: 1. Newly diagnosed and known cases of Diabetes Mellitus with comorbidities who were receiving anti-hyperglycemics and patients who were hospitalized included. 2. Inpatients of either sex or patients aged 18 years and above were included.  Exclusion Criteria: 1. Patients with gestational diabetes were excluded from the study. 2. Out patients are also excluded from our study
Source of data:
The patient demographical data, clinical data, therapeutic data and various other relevant and necessary data collected from: All the patients were monitored from the day of admission to the day of discharge. During the treatment with anti-diabetic drugs the enrolled patients were evaluated clinically every day to assess the clinical outcome. The patients were also monitored for possible Drug Interactions during the course of treatment with Anti-Diabetic drugs.
Data analysis:
All the data was analysed in order to assess the drug utilization in diabetic patients, to evaluate the prescription pattern, drug interactions and other illness associated with Diabetes. Analysis is also based on evaluating the potential drug interactions. The data was analysed and the percentage value was calculated for the use of different class of oral anti-diabetics in medicine unit.
RESULTS:
A total of 201 patients aged 18 years and above admitted to the hospital who were known case of DM and newly detected diabetic patients were enrolled in the study.
Demographic details:
Out of 201 patients, males were 101(50.25%) and females were 100(49.75%). From the analysed data we found that, the large number of diabetic patients were at the age group of 51-60 years (26. 
Co Morbidities in Diabetic patients:
Out of 201 patients, 152 patients (75.62%) were identified with co morbidities and 49 patients (24.37%) were without co morbidities. From the data, Out of 152 co morbid associated patients 92 were encountered with cardiovascular diseases (60.52%), followed by 37 patients were experienced with infectious diseases (24.34%), 12 patients were experienced with respiratory diseases (7.89%) and 11 patients with Renal failure (7.23%). 
Prescription pattern of Anti Diabetic drugs:
Study revealed that out of 201 patients, 137 patients were on Monotherapy (68.15%) followed by 47 patients were on Two drug combination therapy (23.38%), 14 patients were on Three drug combination therapy (6.96%) and 3 patients were on Four drug combination therapy (1.49%). 
DISCUSSION
Drug utilization study is known to be one of the most effective methods to assess and evaluate the physicians prescribing natureand their by to promote rational use of drugs 1. This is a cross sectional study conducted on subjects having diabetes, who visits doctor in tertiary care hospital, essentially focusing on drug utilization among diabetes patients.
The necessity of management of diabetes by drugs is to lessen the morbidity, mortality and to improve the patient's life quality. Patient's demographic details are considered while taking measures for adequate control of plasma glucose including co-morbid conditions. After newly diagnosed; especially when the initial A1C is less than 8%, any available anti-hyperglycaemic drugs are capable of controlling hyperglycaemia. Oral agents can be used as additives for therapeutic effects, especially at lower doses. Individualization is often necessary asinitial choices make patients clinical situations vary widely. So the drug choice for managementshould be based on some considerations, which are mentioned in the following:
 Contraindications  Synergy of mechanisms of action  Therapeutic response  Side effects likely to occur  Hypoglycaemia  Oedema  Weight gain  Cost effectiveness  Convenience and adherence In the clinical situations, the best initial choice is a sulfonylurea, as they are effective as any other. Special directions are to be given for administration of drug, storage, side effects and management of side effects. Pharmacotherapy only by one drug cannot control blood glucose level when highly elevated, will have to employ another drug to gain the adequate response. For example, the combination of sulfonylureas with metformin, has maximum potency to lower the blood glucose levels and favours these agents include low cost. However, there is an in vigorous rationale for using this combination before titrating to full dosage of the first agent and the therapeutic effects are not proportional. Metformin side effects increase progressively like gastrointestinal discomfort for patients at 2,000 mg/day. For example, adding 2-4 mg of glimepiride or 5-10 mg extendedrelease glipizideonce daily to 500-1000 mg metformin with supper reduces blood glucose level without risk of gastrointestinal distress. Insulin is given when oral therapy response is inadequate.Based on individualization of patients clinical situation the approach of insulin in the management of diabetes has to be considered along with oral agents or insulin alone as per the drug therapeutic response on patient.
CONCLUSION
The present study concluded sulfonylureas was the most commonly prescribed oral hypoglycaemic drug in this hospital followed by combination with biguanides (i.e.
